Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

After Some Good Luck, Nio Stock Has a Lot to Prove

Up over 300% for the last year, Nio stock has the attention of serious investors. But for the stock to continue to grow, it must prove it can turn a profit.

Smart Money Should Stay Away from Genius Brands

The bullish case for GNUS stock depends on whether you believe young remote learners will opt to fill their downtime with the company's app.

Sorrento Is Stuck In a Story of Its Own Creation

SRNE stock is up over 230% as speculative investors buy the hope that one of its three Covid-19 approaches will latch on. But what if none of them do?

There are Several Reasons to Trust the Medtronic Rally

Medtronic posted falling sales due to a hit in elective procedures. But rising demand and a strong balance sheet will support MDT stock.

Things Get Complicated When Looking At Nikola Stock

The future of Nikola stock is clearly in delivering on the promise of hydrogen. But in the short term, NKLA needs a traditional approach.